ORIC PHARMACEUTICALS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-59.5M | $-60.5M | $939.0K | $12.9M |
| FY2022 | $-75.1M | $-77.2M | $2.1M | $14.5M |
| FY2023 | $-85.7M | $-86.5M | $849.0K | $15.2M |
| FY2024 | $-112.7M | $-113.9M | $1.2M | $20.2M |
| FY2025 | $-111.0M | $-111.7M | $712.0K | $25.0M |